<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Przybycien-Gaweda PM</submitter><funding>Biomedical Research Council</funding><funding>National Medical Research Council</funding><pagination>3535</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9459953</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(17)</volume><pubmed_abstract>There is a lack of evidence supporting an association between folate and vitamin B12 exposure with cognitive outcomes. We examined serum folate and vitamin B12 and plasma homocysteine in 690 cognitively-normal adults (aged ≥ 55) from the Singapore Longitudinal Aging Study (SLAS-2) followed-up over 4.5 years on incident neurocognitive disorder (NCD): mild cognitive impairment (MCI) and dementia. At follow-up, 5.7% (39) of participants developed NCD (34 MCI and 5 dementia). Comparing with those who remained cognitively-normal, participants progressed to NCD had significantly lower mean baseline vitamin B12 (420 [SD ± 221] vs. 510 [SD ± 290] pmol/L, &lt;i>p&lt;/i> = 0.026), higher homocysteine (14.6 [SD ± 4.2] vs. 12.9 [SD ± 4.3], &lt;i>p&lt;/i> = 0.018) and lower one-carbon index (Z-scores: -0.444 [SD ±</pubmed_abstract><journal>Nutrients</journal><pubmed_title>One-Carbon Metabolism Biomarkers and Risks of Incident Neurocognitive Disorder among Cognitively Normal Older Adults.</pubmed_title><pmcid>PMC9459953</pmcid><funding_grant_id>BMRC/08/1/21/19/567</funding_grant_id><funding_grant_id>NMRC/1108/2007</funding_grant_id><funding_grant_id>NMRC/CIRG/1409/2014</funding_grant_id><pubmed_authors>Rawtaer I</pubmed_authors><pubmed_authors>Gao Q</pubmed_authors><pubmed_authors>Lim WS</pubmed_authors><pubmed_authors>Liew TM</pubmed_authors><pubmed_authors>Yap KB</pubmed_authors><pubmed_authors>Ng TP</pubmed_authors><pubmed_authors>Yap P</pubmed_authors><pubmed_authors>Przybycien-Gaweda PM</pubmed_authors><pubmed_authors>Gwee X</pubmed_authors><pubmed_authors>Lee TS</pubmed_authors><pubmed_authors>Chong MS</pubmed_authors><pubmed_authors>Cheong CY</pubmed_authors></additional><is_claimable>false</is_claimable><name>One-Carbon Metabolism Biomarkers and Risks of Incident Neurocognitive Disorder among Cognitively Normal Older Adults.</name><description>There is a lack of evidence supporting an association between folate and vitamin B12 exposure with cognitive outcomes. We examined serum folate and vitamin B12 and plasma homocysteine in 690 cognitively-normal adults (aged ≥ 55) from the Singapore Longitudinal Aging Study (SLAS-2) followed-up over 4.5 years on incident neurocognitive disorder (NCD): mild cognitive impairment (MCI) and dementia. At follow-up, 5.7% (39) of participants developed NCD (34 MCI and 5 dementia). Comparing with those who remained cognitively-normal, participants progressed to NCD had significantly lower mean baseline vitamin B12 (420 [SD ± 221] vs. 510 [SD ± 290] pmol/L, &lt;i>p&lt;/i> = 0.026), higher homocysteine (14.6 [SD ± 4.2] vs. 12.9 [SD ± 4.3], &lt;i>p&lt;/i> = 0.018) and lower one-carbon index (Z-scores: -0.444 [SD ±</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-19T18:30:18.905Z</modification><creation>2025-04-19T18:30:18.905Z</creation></dates><accession>S-EPMC9459953</accession><cross_references><pubmed>36079793</pubmed><doi>10.3390/nu14173535</doi></cross_references></HashMap>